Allogene Therapeutics Inc. (ALLO)
NASDAQ · Healthcare
Allogene Therapeutics Inc. annual/quarterly total liabilities history from 2019 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Allogene Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 123.4M, a 2.50% decrease year-over-year.
- Allogene Therapeutics Inc. total liabilities for 2025 were 123.4M, a 2.50% decrease from 2024.
- Allogene Therapeutics Inc. total liabilities for 2024 were 126.5M, a 3.12% decrease from 2023.
- Allogene Therapeutics Inc. total liabilities for 2023 were 130.6M, a 15.57% decrease from 2022.
- Allogene Therapeutics Inc. total liabilities for 2022 were 154.7M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Allogene Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $123 |
| 2024 | $127 |
| 2023 | $131 |
| 2022 | $155 |
| 2021 | $126 |
| 2020 | $148 |
| 2019 | $89 |
| Allogene Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $123 |
| 2024-12-31 | $127 |
| 2023-12-31 | $131 |
| 2022-12-31 | $155 |
| 2021-12-31 | $126 |
| 2020-12-31 | $148 |
| 2019-12-31 | $89 |
Allogene Therapeutics Inc. Total Liabilities — FAQ
Allogene Therapeutics Inc. (ALLO) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALLO's total liabilities history?
The chart and table above show Allogene Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.